United States Biotechnology & Medical Research

RetinalGenix Technologies Inc (RTGN)

Track

Track

RetinalGenix Technologies Inc. recorded one notable insider trading transaction recently. Steven Bayern, representing Bayern Capital LLC, filed a proposed sale valued at 727,600 dollars. This activity follows a series of divestment notices from the same shareholder, occurring amidst stagnant stock performance and without any immediate updates regarding the firm's latest earnings report.
Ticker: RTGN Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BAYERN STEVEN 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.16
Quantity 9,700
Value US$30,700
BAYERN STEVEN 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.49
Quantity 10,000
Value US$44,900
BAYERN STEVEN 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
9.40
Quantity 10,000
Value US$94,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-10 2026-06-11 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
49,742
245.88
US$4,640,765 		49,742 245.88 US$4,640,765
2026-02-25 2026-02-26 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
5,338
251.30
US$4,421,811 		5,338 251.30 US$4,421,811
2025-11-07 2025-11-10 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
64,227
401.43
US$4,857,377 		64,227 401.43 US$4,857,377
2025-08-12 2025-08-13 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
100,000
3.54
US$354,000 		100,000 3.54 US$354,000
2025-05-19 2025-05-12 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
100,000
3.52
US$352,000 		100,000 3.52 US$352,000
2024-02-05 2024-02-05 PrS Proposed sale
BAYERN STEVEN

10% Stockholder

Large shareholder
9,700
3.16
US$30,700 		9,700 3.16 US$30,700
2023-11-07 2023-11-07 PrS Proposed sale
BAYERN STEVEN

10% Stockholder

Large shareholder
10,000
4.49
US$44,900 		10,000 4.49 US$44,900
2023-08-31 2023-08-31 PrS Proposed sale
BAYERN STEVEN

10% Stockholder

Large shareholder
10,000
9.40
US$94,000 		10,000 9.40 US$94,000
Explore more

More insider trading research around RetinalGenix Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America